PrEP and PEP Vaccines Can Protect Prisoners from HIV. Most Inmates Have Never Heard of Them.
Author: Margaret R. Moreland, JD, MSLS.
Source: Volume 24, Number 01, Winter 2023 , pp.8-8(1)
< previous article |next article > |return to table of contents
Abstract:
Contributing editor Margaret Moreland reviews study published in American Journal of Men’s Health, Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men” by Pamela Valera, Zaire S. Ali, Diamond Cunningham, Christopher McLaughlin, and Sebastian Aceved, which reported on The Cancer Risk in Incarcerated Men’s Study (CRIIMS), a multi-method research project that examined tobacco, cancer health, and psychosocial factors related to health behaviors among men incarcerated in three northeast U.S. state prisons. The participants’ responses regarding their knowledge of PrEP and PEP revealed that only 3.7% had heard about PrEP and only 3% had heard of PEP.Keywords: HIV; Pre-Exposure Prophylaxis (PrEP); Post-Exposure Prophylaxis (PEP)
Affiliations:
1: Contributing Editor.